Video: Etranacogene Dezaparvovec Has Long-Term Efficacy, Can Expand Eligibility for Hemophilia B
Steven Pipe, MD, explains the long-term efficacy data surrounding etranacogene dezaparvovec in patients with hemophilia B.
Related Articles
Immunology | bioRxiv
bioRxiv – the preprint server for biology, operated by Cold Spring Harbor Laboratory, a research and educational institution
Diagnosing Acute Bacterial vs Viral Rhinosinusitis
American Family Physician Community Blog, Diagnosing Acute Bacterial vs Viral Rhinosinusitis, written by Lilian White, MD.
Enhancing Outcomes With Immunotherapy Agents for Patients With Non-Muscle Invasive Bladder Cancer
Panelists at the 2025 ASCO Genitourinary Cancers Symposium discussed challenges and new approaches to treatment.
Projected Impact and Cost-Effectiveness of Novel Molecular Blood-Based or Stool-Based Screening Tests for Colorectal Cancer | Annals of Internal Medicine
Background: Cell-free DNA blood tests (cf-bDNA) and next-generation stool tests could change colorectal cancer (CRC) screening. Objective: To estimate the clinical and economic impacts of…
Refining CRS and ICANS Management in CAR T-Cell Therapy: Understanding Evolving Diagnostic Criteria and Treatment Strategies
C. Brooke Adams, PharmD, BCOP, discusses the evolving diagnostic criteria and management strategies for cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS)…
Treatment options for preventing autoimmune-mediated congenital heart block: a systematic review
Objective Complete congenital heart block (CHB) due to anti-Ro/La antibodies in pregnancy can lead to adverse fetal outcomes and neonatal death. National and international guidelines…
Use and Discontinuation Rates of Long‐Acting Injectable Antipsychotics Between Race/Ethnicity in Older Adults Using Medicaid Databases
Objective The primary objective of this study was to assess the prescribing patterns of long acting injectable (LAI) antipsychotics in an older adult population. Secondary…
Primary Care in Rochester and Kasson
Water makes up between 50% and 70% of your body weight. It’s essential for every cell, tissue and organ in your body. Water removes waste…
How to use mTOR inhibitors in children
Paediatricians across many specialities and pharmacists are increasingly being asked to prescribe, or jointly look after, children treated with mammalian target of rapamycin (mTOR) inhibitors…
Cabozantinib Extends Survival in RCC Patients with Untreated Brain Metastases
Data from the phase 2 CABRAMET trial suggests the potential of cabozantinib for treatment of brain metastases from renal cell carcinoma (RCC).